National guidance is neededfor ViagraBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7152.165b (Published 18 July 1998) Cite this as: BMJ 1998;317:165
- Richard Harling
The government should urgently review the mechanism for introducing newly licensed expensive drugs into clinical practice, doctors urged at the BMA's annual representative meeting last week.
Major concerns were raised about the introduction of sildenafil (Viagra), which is expected to be licensed for use in Britain in September. Tessa Jowell, the minister for public health, has stated that …